Human leucocyte antigen B*57.01 allelic gene is uncommon in Nigerians: An implication for antiretroviral therapy among the HIV/AIDS cohort.
作者信息
Owojuyigbe Temilola Oludunmomi, Bolarinwa Rahman Ayodele, Adesina Adetunji S, Ademosun Abdulwaheed Adewale, Akinola Norah Olubunmi
机构信息
Department of Haematology and Immunology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
Department of Haematology and Blood Transfusion, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
出版信息
Indian J Med Res. 2024 May;159(5):530-533. doi: 10.25259/ijmr_1263_23.
Abstract
摘要
相似文献
1
Human leucocyte antigen B*57.01 allelic gene is uncommon in Nigerians: An implication for antiretroviral therapy among the HIV/AIDS cohort.人类白细胞抗原B*57.01等位基因在尼日利亚人中并不常见：对艾滋病毒/艾滋病队列抗逆转录病毒治疗的启示。
Indian J Med Res. 2024 May;159(5):530-533. doi: 10.25259/ijmr_1263_23.
2
Absence of human leukocyte antigen-B*57:01 amongst patients on antiretroviral therapy in Nigeria: Implications for use of abacavir.尼日利亚接受抗逆转录病毒治疗患者中人类白细胞抗原-B*57:01缺失情况：对阿巴卡韦使用的影响
Niger Postgrad Med J. 2019 Oct-Dec;26(4):195-198. doi: 10.4103/npmj.npmj_75_19.
3
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.人类白细胞抗原与人类免疫缺陷病毒1型：杂合子优势及B*35-Cw*04劣势
Science. 1999 Mar 12;283(5408):1748-52. doi: 10.1126/science.283.5408.1748.
4
Learning from the elite.向精英学习。
Nature. 2010 Jul 15;466(7304):S4. doi: 10.1038/nature09235.
5
The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.在长期不进展者中，与保护性人类白细胞抗原 I 类等位基因相关的是 HIV 特异性 CD8(+) T 细胞的扩增能力，而不是其质量。
Immunology. 2011 Nov;134(3):305-13. doi: 10.1111/j.1365-2567.2011.03490.x.
6
Human leukocyte antigen profile in HIV-1 infected individuals and AIDS patients from Chongqing, China.中国重庆地区HIV-1感染者及艾滋病患者的人类白细胞抗原谱
Microbiol Immunol. 2009 Sep;53(9):512-23. doi: 10.1111/j.1348-0421.2009.00150.x.
7
Genetics. First-class control of HIV-1.遗传学。HIV-1的一流控制。
Science. 2010 Dec 10;330(6010):1488-90. doi: 10.1126/science.1200035.
8
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.KIR3DS1与HLA - B之间的上位性相互作用延缓了艾滋病的进展。
Nat Genet. 2002 Aug;31(4):429-34. doi: 10.1038/ng934. Epub 2002 Jul 22.
9
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.MHC I类分子中单个氨基酸变化对艾滋病进展速率的影响。
N Engl J Med. 2001 May 31;344(22):1668-75. doi: 10.1056/NEJM200105313442203.
10
Prevalence and clinical correlates of metabolic syndrome in Nigerians living with human immunodeficiency virus/acquired immunodeficiency syndrome.代谢综合征在尼日利亚艾滋病毒/获得性免疫缺陷综合征患者中的流行情况及临床相关性。
Metab Syndr Relat Disord. 2012 Oct;10(5):373-9. doi: 10.1089/met.2012.0050. Epub 2012 Jul 16.
本文引用的文献
1
Estimation of HIV prevalence and burden in Nigeria: a Bayesian predictive modelling study.尼日利亚艾滋病毒流行率和负担的估计：一项贝叶斯预测模型研究。
EClinicalMedicine. 2023 Jul 20;62:102098. doi: 10.1016/j.eclinm.2023.102098. eCollection 2023 Aug.
2
Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV.人类白细胞抗原 B*5701 对 HIV 感染者 20 年存活率的影响。
PLoS One. 2021 Aug 9;16(8):e0255834. doi: 10.1371/journal.pone.0255834. eCollection 2021.
3
Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.在西非和中非的 HIV 感染者中人类白细胞抗原 HLA-B*57:01 的流行率。
BMC Immunol. 2021 Jul 22;22(1):48. doi: 10.1186/s12865-021-00427-7.
4
Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV.在一大群感染艾滋病毒的患者中，阿巴卡韦不良反应与HLA - B*57:01单倍型的相关性。
Pharmacogenet Genomics. 2020 Oct;30(8):167-174. doi: 10.1097/FPC.0000000000000409.
5
Absence of human leukocyte antigen-B*57:01 amongst patients on antiretroviral therapy in Nigeria: Implications for use of abacavir.尼日利亚接受抗逆转录病毒治疗患者中人类白细胞抗原-B*57:01缺失情况：对阿巴卡韦使用的影响
Niger Postgrad Med J. 2019 Oct-Dec;26(4):195-198. doi: 10.4103/npmj.npmj_75_19.
6
HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia.哥伦比亚初治 HIV 感染患者中 HLA-B*57:01 等位基因的流行率。
BMC Infect Dis. 2019 Sep 9;19(1):793. doi: 10.1186/s12879-019-4415-3.
7
Genetic variations among three major ethnic groups in Nigeria using RAPD.利用随机扩增多态性DNA（RAPD）技术研究尼日利亚三个主要民族群体的基因变异。
Mol Biol Res Commun. 2018 Jun;7(2):51-58. doi: 10.22099/mbrc.2018.26098.1280.
8
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects.北美HIV感染受试者中HLA - B*57:01等位基因的流行率以及等位基因检测对HLA - B*57:01阴性受试者中阿巴卡韦相关超敏反应发生率的影响。
BMC Infect Dis. 2017 Apr 11;17(1):256. doi: 10.1186/s12879-017-2331-y.
9
10
HLA B*5701 status, disease progression, and response to antiretroviral therapy.人类白细胞抗原 B*5701 状态、疾病进展和抗逆转录病毒治疗反应。
AIDS. 2013 Oct 23;27(16):2587-92. doi: 10.1097/01.aids.0000432613.95455.71.
Zotero 插件